| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma. | Blood | 2013 | 3.03 |
| 2 | Randomized comparison of pegfilgrastim day 4 versus day 2 for the prevention of chemotherapy-induced leukocytopenia. | Ann Oncol | 2011 | 1.07 |
| 3 | Dose-escalated CHOP plus etoposide (MegaCHOEP) followed by repeated stem cell transplantation for primary treatment of aggressive high-risk non-Hodgkin lymphoma. | Blood | 2005 | 1.00 |
| 4 | Rituximab in high-grade lymphoma. | Semin Hematol | 2010 | 0.92 |